Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)
Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%
Dr Reddys Laboratories shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2026 it was 833M, down 0.1% from the year before. Over ten years it grew -0.3% a year on average. The highest annual figure on record is 855M in fiscal 2016.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | 833M | -0.1% |
| FY2025 | Mar 31, 2025 | 834M | +0.1% |
| FY2024 | Mar 31, 2024 | 834M | +0.2% |
| FY2023 | Mar 31, 2023 | 832M | +0.0% |
| FY2022 | Mar 31, 2022 | 832M | +0.0% |
| FY2021 | Mar 31, 2021 | 832M | +0.1% |
| FY2020 | Mar 31, 2020 | 830M | -0.1% |
| FY2019 | Mar 31, 2019 | 831M | +0.0% |
| FY2018 | Mar 31, 2018 | 831M | -0.5% |
| FY2017 | Mar 31, 2017 | 835M | -2.4% |
| FY2016 | Mar 31, 2016 | 855M | – |
See a number that looks wrong?